Screening assays of new anti-tuberculosis drugs (2002)
- Authors:
- USP affiliated authors: SILVA, CELIO LOPES - FMRP
- Unidades: FMRP
- Subjects: TUBERCULOSE (TRATAMENTO); BIOQUÍMICA
- Language: Inglês
- Imprenta:
- Publisher: REDE-TB
- Place of publication: Rio de Janeiro
- Date published: 2002
- Conference title: Workshop da Rede Brasileira de Pesquisa em Tuberculose
-
ABNT
DE SOUZA, A. O.; SILVA, Célio Lopes. Screening assays of new anti-tuberculosis drugs. Anais.. Rio de Janeiro: REDE-TB, 2002. -
APA
De Souza, A. O., & Silva, C. L. (2002). Screening assays of new anti-tuberculosis drugs. In . Rio de Janeiro: REDE-TB. -
NLM
De Souza AO, Silva CL. Screening assays of new anti-tuberculosis drugs. 2002 ; -
Vancouver
De Souza AO, Silva CL. Screening assays of new anti-tuberculosis drugs. 2002 ; - Cell wall components of ac actinomycetis involved in the pathogeny of actinomicotic mycetona
- Mouse toxicity induced by lipids and cell wall isolated from actinomycetis
- A single dose of a DNA vaccine encoding Apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against Tuberculosis in Mycobacterium bovis BCG-primed mice
- Expression of IL-2 mRNA in susceptible mice infected with virulent Paracoccidioides brasiliensis
- Echocardiographic assessment of muscarinic receptor plasmid DNA immunized mice
- Tumor necrosis factor macrophage activation are important in clearance of nocardia brasiliensis from the livers and spleen of mice
- Participacao de glicolipideos na imunopatologia da infeccao por mycobacterium bovis (bcg)
- Paracoccidioides brasiliensis polysaccharide having granuloma-inducing toxic and macrophage - stimulating activity
- Role of cord factor in the modulation of infection caused by mycobacteria
- Inflammation induce by mycolic acid-containing glycolipidis of mycobacteruam bovis ( bcg )
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
